Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein

The recent outbreak of Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) infection has led to more than 800 laboratory-confirmed MERS cases with a high case fatality rate (∼35%), posing a serious threat to global public health and calling for the development of effective and safe therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Shuai, Liu, Qi, Wang, Qian, Sun, Zhiwu, Su, Shan, Du, Lanying, Ying, Tianlei, Lu, Lu, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114414/
https://www.ncbi.nlm.nih.gov/pubmed/25451066
http://dx.doi.org/10.1016/j.virusres.2014.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114414/
https://www.ncbi.nlm.nih.gov/pubmed/25451066
http://dx.doi.org/10.1016/j.virusres.2014.10.007

Ejemplares similares